Keywords:
bachadon miomasi, leyomioma, klinik omillar, ijtimoiy omillar, semizlik, vitamin D, reproduktiv anamnez, hayot sifati.References
1. Barmanasheva Z et al. Prevalence and risk factors of uterine fibroids. Gynecol Endocrinol. 2025;41(2):130-7.
2. Bedggood E, Sun J, Ghosh S, Pathiraja V, Rathnayake N, Eleje GU et al. Evaluating treatment options for symptomatic uterine fibroids: a systematic review and meta-analysis. Front Glob Wom- ens Health. 2025;6:1601341.
3. Bulun SE et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis and future directions. Endo- crinol Rev. 2022;43(4):678-719.
4. Ciebiera M et al. Vitamin D and uterine fibroids: pathophys- iology and clinical implications. Int J Mol Sci. 2026;27(1):45-58.
5. Donnez J, Dolmans MM. Current and emerging treatment options for uterine fibroids. Drugs. 2022;82(2):145-60.
6. Evans J. The impact of health literacy on uterine fibroid diag- nosis and treatment. Front Reprod Health. 2024;6:112233.
7. Evans J. The role of socioeconomic status in uterine fibroid awareness, perceptions, and treatment. Womens Health Issues. 2024;34(1):50-8.
8. Ivanova M et al. The association of vitamin D with uterine fibroids in reproductive medicine: a literature review. Reprod Biomed Online. 2024;48(3):320-8.
9. Jahangiri Y. Uterine fibroids: a narrative review of epidemi- ology and management. Gynecol Pelvic Med. 2024;7:10206.
10. Katon JG, Plowden TC, Marsh EE. Racial disparities in uterine fibroids: a systematic review. Fertil Steril. 2023;119(4):789-98.
11. Keizer AL et al. Modifiable prognostic factors in uterine fibroid development: a systematic review. J Obstet Gynaecol. 2024;44(2):150-60.
12. Kim HM et al. The integrative health status of women with uterine fibroids. BMC Womens Health. 2025;25(1):100-10.
13. Kim JJ, Sefton EC. The pathogenesis of uterine fibroids: current understanding and future directions. Fertil Steril. 2024;121(3):345-56.
14. Louie M et al. Racial and socioeconomic dispari- ties in uterine fibroid treatment. Amer J Obstet Gynecol. 2025;232(3):345-53.
15. Lumsden MA, Hamoodi I, Gupta J, Hickey M. Uter- ine fibroids: rapid evidence review. Amer Fam Physician. 2025;102(10):605-14.
16. Marsh EE et al. Burden, disparities, and unmet needs in uter- ine fibroids. Semin Reprod Med. 2022;40(1):10-20.
17. Mension E, Calaf J, Chapron C, Dolmans MM, Donnez J, Mar- cellin L et al. An update on the management of uterine fibroids: personalized medicine or guidelines? J Endometriosis Uterine Dis. 2024:100080.
18. Munro MG. The epidemiology and pathogenesis of uterine fibroids. Int J Gynecol Obstet. 2025;170(1):1-10.
19. Neumann B et al. The impact of fibroid treatments on qual- ity of life and mental health: a systematic review. Qual Life Res. 2024;33(5):1201-12.
20. Qin H et al. Association between obesity and the risk of uter- ine fibroids: a systematic review and meta-analysis. J Epidemiol Community Health. 2021;75(2):197-204.
21. Siegel EL et al. Associations between earlier menarche and fibroid severity. J Womens Health. 2025;34(2):210-8.
22. Stewart EA et al. Uterine fibroids. Lancet. 2021;397(10277):293-305.
